Global Molecular Diagnostics Genetic Testing Market Research Report – Segmented By Technology (Massively Parallel Sequencing, Polymer Chain Reaction, Array, Fluorescent In-situ Hybridization, Isothermal Nucleic Amplification Techniques, Others), By Type (Prenatal & Newborn Testing, Health & Wellness Predisposition, Carrier Testing, Pharmacogenomic Testing, Others), By End – User (Diagnostic Laboratories, Hospitals & Clinics, Others), and Region- Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Molecular Diagnostics Genetic Testing Market– Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 Chapter 2. Molecular Diagnostics Genetic Testing Market– Executive Summary
2.1     Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2     Key Trends & Insights
            2.2.1     Demand Side
            2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 Chapter 3. Molecular Diagnostics Genetic Testing Market– Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
Chapter 4. Molecular Diagnostics Genetic Testing Market- Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4     PESTLE Analysis
4.5     Porters Five Force Model
            4.5.1    Bargaining Power of Suppliers
            4.5.2    Bargaining Powers of Customers
            4.5.3    Threat of New Entrants
            4.5.4    Rivalry among Existing Players
            4.5.5    Threat of Substitutes
 Chapter 5. Molecular Diagnostics Genetic Testing Market- Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 Chapter 6. Molecular Diagnostics Genetic Testing Market-  BY TECHNOLOGY
6.1    Introduction/Key Findings   
6.2    Massively Parallel Sequencing
6.3    Polymer Chain Reaction
6.4    Array
6.5    Fluorescent In-situ Hybridization
6.6    Isothermal Nucleic Amplification Techniques
6.7    Others
6.8    Y-O-Y Growth trend Analysis    BY TECHNOLOGY
6.9      Absolute $ Opportunity Analysis    BY TECHNOLOGY, 2023-2030
Chapter 7. Molecular Diagnostics Genetic Testing Market-  By Type
7.1    Introduction/Key Findings    
7.2    Prenatal & Newborn Testing
7.3    Health & Wellness Predisposition
7.4    Carrier Testing
7.5    Pharmacogenomic Testing
7.6    Others
7.7    Y-O-Y Growth trend Analysis    By Type
7.8      Absolute $ Opportunity Analysis    By Type, 2023-2030
Chapter 8. Molecular Diagnostics Genetic Testing Market - By End–User 
8.1    Introduction/Key Findings    
8.2    Diagnostic Laboratories
8.3    Hospitals & Clinics
8.4    Others
8.5    Y-O-Y Growth trend Analysis By End–User
8.6      Absolute $ Opportunity Analysis By End–User, 2023-2030
Chapter 9. Molecular Diagnostics Genetic Testing Market, By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
            9.1.1    By Country
                        9.1.1.1    U.S.A.
                        9.1.1.2    Canada
                        9.1.1.3    Mexico
9.2     BY TECHNOLOGY
9.3    By Type
9.4    By End–User
9.5    Countries & Segments - Market Attractiveness Analysis
9.6    Europe
            9.6.1    By Country
                        9.6.1.1    U.K.                         
                        9.6.1.2    Germany
                        9.6.1.3    France
                        9.6.1.4    Italy
                        9.6.1.5    Spain
                        9.6.1.6    Rest of Europe

9.7       BY TECHNOLOGY
9.8    By Type
9.9    By End–User
9.10    Countries & Segments - Market Attractiveness Analysis
9.11    Asia Pacific
            9.11.1    By Country
                        9.11.1.1    China
                        9.11.1.2    Japan
                        9.11.1.3    South Korea
                        9.11.1.4    India      
                        9.11.1.5    Australia & New Zealand
                        9.11.1.6    Rest of Asia-Pacific
9.12       BY TECHNOLOGY
9.13    By Type
9.14    By End–User
9.15    Countries & Segments - Market Attractiveness Analysis
9.16    South America
            9.16.1    By Country
                        9.16.1.1    Brazil
                        9.16.1.2    Argentina
                        9.16.1.3    Colombia
                        9.16.1.4    Chile
                        9.16.1.5    Rest of South America
9.17       BY TECHNOLOGY
9.18    By Type
9.19    By End–User
9.20    Countries & Segments - Market Attractiveness Analysis
9.21    Middle East & Africa
            9.21.1    By Country
                        9.21.1.1    United Arab Emirates 
                        9.21.1.2    Saudi Arabia
                        9.21.1.3    Qatar
                        9.21.1.4    Israel
                        9.21.1.5    South Africa
                        9.21.1.6    Nigeria
                        9.21.1.7    Kenya
                        9.21.1.8    Egypt
                        9.21.1.9    Rest of MEA
9.22       BY TECHNOLOGY
9.23    By Type
9.24    By End–User
9.25    Countries & Segments - Market Attractiveness Analysis
 Chapter 10. Molecular Diagnostics Genetic Testing Market– Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Abbot Laboratories 
10.2    Danaher Corporation
10.3    Bio-Rad Laboratories Inc. 
10.4    Myriad Genetics 
10.5    AmGen Inc
10.6    Eurofins Genoma
10.7    Color Genomics 
10.8    AncestryDNA
10.9    F. Hoffman La-Roche Ltd. 
10.10    Seimens AG


 

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

The Global Molecular Diagnostics Genetic Testing Market was valued at USD 1.2 billion and is projected to reach a market size of USD 2.69 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 10.6%. 

Increasing cases of autoimmune disease and development in technological advancements and innovations are the drivers.

 Based on type, the Global Molecular Diagnostic Genetic Testing is segmented into Prenatal and newborn Testing, Health and wellness Predisposition, Carrier Testing, Pharmacogenomic Testing, and Others.

The United States of America is the most dominant country in the region of North America for the Global Molecular Diagnostic Genetic Testing Market.

Abbot Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., Myriad Genetics, AmGen Inc., Eurofins Genoma, Color Genomics, AncestryDNA, F. Hoffman La-Roche Ltd., Seimens AG.